Evaluation of renal function in a patient with SARS-COV-2 infection from Rapid Response Center at Al-Bayda City

Abstract

Acute kidney injury (AKI) occurs in up to half of patients hospitalized with coronavirus disease 2019 (SARS-COV-2). The longitudinal effects of SARS-COV-2–associated AKI on kidney function remain unknown. This study aimed to analyze the characteristics of renal function in patients diagnosed with SARS-COV-2. In this retrospective study, cases were confirmed as SARS-COV-2 cases from The First Monitoring and Rapid Response Center to combat the SARS-COV-2 Corona Epidemic in Al-Bayda City from Jun 2020 to April 2021. The registry comprised laboratory findings related to renal function which were summarized, and the estimated urea rate and creatinine rate were also calculated to assess the renal function. A total of 402 patients were diagnosed with COVID-19, 186 (46%) were females and 216 (54%) were males. Blood urea was not abnormally elevated in all patients, and serum creatinine was abnormally elevated in only 33.0% (n= 136). Urea and creatinine were generally increased during the course of COVID-19. Additional research, preferably sizing up to prospective cohort studies, is required to verify these conclusions.